<p> In this week’s podcast, <em>Neurology Today</em>’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.</p>

<description>&lt;p&gt;&lt;span style= "font-size: 10.0pt; line-height: 115%; font-family: 'Trebuchet MS',sans-serif; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"&gt; In this week’s podcast, &lt;em&gt;Neurology Today&lt;/em&gt;’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.&lt;/span&gt;&lt;/p&gt;</description>

Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s

In this week’s podcast, Neurology Today’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.

Neurology Today in 5

Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s

Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s

Description